AMGEN Overview
AMGEN Target Price
Analysts' 12-month price predictions for AMGN.
Share Price
$299.02
Average Target Price
$310.00
3.7% upside
3.7% upside2 analysts in the last 4 months
High: $315 | Low: $305
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-02 | UBSTrung Huynh | $315 | 5.3% upside |  |
| 2025-04-22 | Cantor Fitzgerald | $305 | 2% upside | |
| 2025-03-05 | Johnson Rice | $294 |  1.7% downside | |
| 2024-11-12 | JefferiesMichael Yee | $380 | 27.1% upside | |
| 2024-11-12 | Cantor FitzgeraldOlivia Brayer | $405 | 35.4% upside | |
| 2024-10-21 | Morgan StanleyTerence Flynn | $319 | 6.7% upside | |
| 2024-10-16 | Goldman SachsSalveen Richter | $369 | 23.4% upside | |
| 2024-10-07 | BarclaysCarter Gould | $315 | 5.3% upside | |
| 2024-09-25 | BMO CapitalEvan David Seigerman | $362 | 21.1% upside | |
| 2024-09-25 | Raymond JamesChristopher Raymond | $344 | 15% upside | |
| 2024-09-25 | Robert W. BairdBrian Skorney | $215 | 28.1% downside | |
| 2024-08-07 | Wells FargoMohit Bansal | $335 | 12% upside | |
| 2024-08-06 | Morgan StanleyTerence Flynn | $303 | 1.3% upside | |
| 2024-06-14 | RBC CapitalGregory Renza | $332 | 11% upside | |
| 2024-05-17 | OppenheimerJay Olson | $380 | 27.1% upside | |
| 2024-05-09 | Mizuho SecuritiesSalim Syed | $235 | 21.4% downside | |
| 2024-05-03 | Morgan StanleyTerence Flynn | $310 | 3.7% upside | |
| 2024-05-03 | BMO CapitalEvan David Seigerman | $355 | 18.7% upside | |
| 2024-05-03 | UBSColin Bristow | $307 | 2.7% upside | |
| 2024-05-03 | BarclaysCarter Gould | $300 | 0.3% upside | |
| 2024-04-17 | Wells FargoMohit Bansal | $320 | 7% upside | |
| 2023-09-13 | OppenheimerJay Olson | $280 | 6.4% downside | |
| 2023-09-13 | JefferiesMichael Yee | $310 | 3.7% upside | |
| 2023-04-12 | Wells FargoMohit Bansal | $265 | 11.4% downside | |
| 2023-03-10 | Wells FargoMohit Bansal | $275 | 8% downside | |
| 2023-02-02 | Leerink Partners | $267 | 10.7% downside | |
| 2023-02-01 | RBC Capital | $258 | 13.7% downside | |
| 2023-02-01 | Oppenheimer | $294 | 1.7% downside | |
| 2023-02-01 | Cowen & Co. | $289 | 3.4% downside | |
| 2023-02-01 | BMO Capital | $253 | 15.4% downside | |
| 2023-01-03 | Wells Fargo | $285 | 4.7% downside | |
| 2022-12-22 | Leerink Partners | $282 | 5.7% downside | |
| 2022-12-13 | Piper Sandler | $299 | 0% upside | |
| 2022-12-06 | Oppenheimer | $310 | 3.7% upside | |
| 2022-12-05 | Raymond JamesChristopher Raymond | $297 | 0.7% downside | |
| 2022-11-18 | Credit Suisse | $240 | 19.7% downside | |
| 2022-10-31 | BarclaysCarter Gould | $234 | 21.7% downside | |
| 2022-08-09 | Atlantic Equities | $182 | 39.1% downside | |
| 2022-08-05 | RBC Capital | $236 | 21.1% downside | |
| 2022-08-05 | Piper Sandler | $265 | 11.4% downside | |
| 2022-07-15 | Morgan Stanley | $253 | 15.4% downside | |
| 2022-06-03 | OppenheimerJay Olson | $290 | 3% downside | |
| 2022-05-10 | Mizuho SecuritiesSalim Syed | $208 | 30.4% downside | |
| 2022-04-29 | BMO CapitalEvan Seigerman | $243 | 18.7% downside | |
| 2022-04-16 | BarclaysCarter Gould | $236 | 21.1% downside | |
| 2022-02-21 | BMO CapitalEvan David Seigerman | $240 | 19.7% downside | |
| 2022-02-08 | UBSColin Bristow | $232 | 22.4% downside | |
| 2022-02-08 | RBC CapitalKennen MacKay | $218 | 27.1% downside | |
| 2022-02-08 | Piper SandlerChristopher Raymond | $255 | 14.7% downside | |
| 2022-01-27 | Cowen & Co.Yaron Werber | $275 | 8% downside | |